ID   RD23B_RAT               Reviewed;         415 AA.
AC   Q4KMA2; Q0D2G8; Q5CZZ8; Q6IRD5;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   02-AUG-2005, sequence version 1.
DT   29-MAY-2024, entry version 136.
DE   RecName: Full=UV excision repair protein RAD23 homolog B;
GN   Name=Rad23b;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Heart, Lung, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   PROTEIN SEQUENCE OF 7-14; 37-45; 52-60 AND 205-212, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain, and Hippocampus;
RA   Lubec G., Chen W.-Q., Kang S.U., Lubec S.;
RL   Submitted (SEP-2007) to UniProtKB.
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-174; THR-186; SER-199 AND
RP   TYR-202, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-155 AND SER-160, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Multiubiquitin chain receptor involved in modulation of
CC       proteasomal degradation. Binds to polyubiquitin chains. Proposed to be
CC       capable to bind simultaneously to the 26S proteasome and to
CC       polyubiquitinated substrates and to deliver ubiquitinated proteins to
CC       the proteasome. May play a role in endoplasmic reticulum-associated
CC       degradation (ERAD) of misfolded glycoproteins by association with
CC       PNGase and delivering deglycosylated proteins to the proteasome (By
CC       similarity). {ECO:0000250}.
CC   -!- FUNCTION: Involved in global genome nucleotide excision repair (GG-NER)
CC       by acting as component of the XPC complex. Cooperatively with Cetn2
CC       appears to stabilize Xpc. May protect Xpc from proteasomal degradation
CC       (By similarity). {ECO:0000250}.
CC   -!- FUNCTION: The XPC complex is proposed to represent the first factor
CC       bound at the sites of DNA damage and together with other core
CC       recognition factors, Xpa, RPA and the TFIIH complex, is part of the
CC       pre-incision (or initial recognition) complex. The XPC complex
CC       recognizes a wide spectrum of damaged DNA characterized by distortions
CC       of the DNA helix such as single-stranded loops, mismatched bubbles or
CC       single-stranded overhangs. The orientation of XPC complex binding
CC       appears to be crucial for inducing a productive NER. XPC complex is
CC       proposed to recognize and to interact with unpaired bases on the
CC       undamaged DNA strand which is followed by recruitment of the TFIIH
CC       complex and subsequent scanning for lesions in the opposite strand in a
CC       5'-to-3' direction by the NER machinery. Cyclobutane pyrimidine dimers
CC       (CPDs) which are formed upon UV-induced DNA damage esacpe detection by
CC       the XPC complex due to a low degree of structural perurbation. Instead
CC       they are detected by the UV-DDB complex which in turn recruits and
CC       cooperates with the XPC complex in the respective DNA repair. In vitro,
CC       the XPC:RAD23B dimer is sufficient to initiate NER; it preferentially
CC       binds to cisplatin and UV-damaged double-stranded DNA and also binds to
CC       a variety of chemically and structurally diverse DNA adducts.
CC       XPC:RAD23B contacts DNA both 5' and 3' of a cisplatin lesion with a
CC       preference for the 5' side. Xpc:Rad22b induces a bend in DNA upon
CC       binding. Xpc:Rad23b stimulates the activity of DNA glycosylases Tdg and
CC       Smug1 (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Component of the XPC complex composed of XPC, RAD23B and
CC       CETN2. Interacts with NGLY1 and PSMC1. Interacts with ATXN3. Interacts
CC       with AMFR. Interacts with VCP; the interaction is indirect and mediated
CC       by NGLY1 (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the RAD23 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC070960; AAH70960.1; -; mRNA.
DR   EMBL; BC090351; AAH90351.1; -; mRNA.
DR   EMBL; BC098674; AAH98674.1; -; mRNA.
DR   EMBL; BC111406; AAI11407.1; -; mRNA.
DR   RefSeq; NP_001020446.1; NM_001025275.1.
DR   AlphaFoldDB; Q4KMA2; -.
DR   BMRB; Q4KMA2; -.
DR   SMR; Q4KMA2; -.
DR   BioGRID; 255730; 63.
DR   IntAct; Q4KMA2; 53.
DR   STRING; 10116.ENSRNOP00000021629; -.
DR   GlyGen; Q4KMA2; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q4KMA2; -.
DR   PhosphoSitePlus; Q4KMA2; -.
DR   jPOST; Q4KMA2; -.
DR   PaxDb; 10116-ENSRNOP00000021629; -.
DR   Ensembl; ENSRNOT00000021629.7; ENSRNOP00000021629.4; ENSRNOG00000016137.7.
DR   Ensembl; ENSRNOT00055030940; ENSRNOP00055024925; ENSRNOG00055018256.
DR   Ensembl; ENSRNOT00060016552; ENSRNOP00060012933; ENSRNOG00060009806.
DR   Ensembl; ENSRNOT00065025298; ENSRNOP00065019824; ENSRNOG00065015267.
DR   GeneID; 298012; -.
DR   KEGG; rno:298012; -.
DR   UCSC; RGD:1562958; rat.
DR   AGR; RGD:1562958; -.
DR   CTD; 5887; -.
DR   RGD; 1562958; Rad23b.
DR   eggNOG; KOG0011; Eukaryota.
DR   GeneTree; ENSGT00390000012078; -.
DR   HOGENOM; CLU_040364_0_1_1; -.
DR   InParanoid; Q4KMA2; -.
DR   OMA; PHMLEPI; -.
DR   OrthoDB; 158575at2759; -.
DR   PhylomeDB; Q4KMA2; -.
DR   TreeFam; TF101216; -.
DR   Reactome; R-RNO-532668; N-glycan trimming in the ER and Calnexin/Calreticulin cycle.
DR   Reactome; R-RNO-5689877; Josephin domain DUBs.
DR   Reactome; R-RNO-5696394; DNA Damage Recognition in GG-NER.
DR   Reactome; R-RNO-5696395; Formation of Incision Complex in GG-NER.
DR   PRO; PR:Q4KMA2; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000016137; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0000502; C:proteasome complex; IEA:UniProtKB-KW.
DR   GO; GO:0071942; C:XPC complex; ISS:UniProtKB.
DR   GO; GO:0003684; F:damaged DNA binding; IEA:InterPro.
DR   GO; GO:0140612; F:DNA damage sensor activity; ISO:RGD.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; ISO:RGD.
DR   GO; GO:0070628; F:proteasome binding; IBA:GO_Central.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0043130; F:ubiquitin binding; IBA:GO_Central.
DR   GO; GO:0098761; P:cellular response to interleukin-7; ISO:RGD.
DR   GO; GO:0006974; P:DNA damage response; ISO:RGD.
DR   GO; GO:0048568; P:embryonic organ development; IEP:RGD.
DR   GO; GO:0006289; P:nucleotide-excision repair; ISO:RGD.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   CDD; cd14377; UBA1_Rad23; 1.
DR   CDD; cd14428; UBA2_HR23B; 1.
DR   CDD; cd16126; Ubl_HR23B; 1.
DR   Gene3D; 1.10.8.10; DNA helicase RuvA subunit, C-terminal domain; 2.
DR   Gene3D; 1.10.10.540; XPC-binding domain; 1.
DR   InterPro; IPR004806; Rad23.
DR   InterPro; IPR041811; RAD23A/B_UBA1.
DR   InterPro; IPR006636; STI1_HS-bd.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like_sf.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   InterPro; IPR015360; XPC-bd.
DR   InterPro; IPR036353; XPC-bd_sf.
DR   NCBIfam; TIGR00601; rad23; 1.
DR   PANTHER; PTHR10621; UV EXCISION REPAIR PROTEIN RAD23; 1.
DR   PANTHER; PTHR10621:SF13; UV EXCISION REPAIR PROTEIN RAD23 HOMOLOG B; 1.
DR   Pfam; PF00627; UBA; 2.
DR   Pfam; PF00240; ubiquitin; 1.
DR   Pfam; PF09280; XPC-binding; 1.
DR   PRINTS; PR01839; RAD23PROTEIN.
DR   SMART; SM00727; STI1; 1.
DR   SMART; SM00165; UBA; 2.
DR   SMART; SM00213; UBQ; 1.
DR   SUPFAM; SSF46934; UBA-like; 2.
DR   SUPFAM; SSF54236; Ubiquitin-like; 1.
DR   SUPFAM; SSF101238; XPC-binding domain; 1.
DR   PROSITE; PS50030; UBA; 2.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   Cytoplasm; Direct protein sequencing; DNA damage; DNA repair; Nucleus;
KW   Phosphoprotein; Proteasome; Reference proteome; Repeat;
KW   Ubl conjugation pathway.
FT   CHAIN           1..415
FT                   /note="UV excision repair protein RAD23 homolog B"
FT                   /id="PRO_0000287582"
FT   DOMAIN          1..79
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   DOMAIN          188..228
FT                   /note="UBA 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   DOMAIN          274..317
FT                   /note="STI1"
FT   DOMAIN          370..410
FT                   /note="UBA 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   REGION          80..175
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          334..355
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        81..107
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        119..141
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        159..175
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         155
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         174
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         186
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         199
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         202
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
SQ   SEQUENCE   415 AA;  43497 MW;  221022C803418390 CRC64;
     MQVTLKTLQQ QTFKIDIDPE ETVKALKEKI ESEKGKDAFP VAGQKLIYAG KILSDDTALK
     EYKIDEKNFV VVMVTKPKAV TSAVPATTQQ SSSPSTTTVS SSPAAAVAQA PAPTPALAPT
     STPASTTPAS TTASSEPAPT GATQPEKPAE KPAQTPVLTS PAPADSTPGD SSRSNLFEDA
     TSALVTGQSY ENMVTEIMSM GYEREQVIAA LRASFNNPDR AVEYLLMGIP GDRESQAVVD
     PPPQAVSTGT PQSPAVAAAA ATTTATTTTT SGGHPLEFLR NQPQFQQMRQ IIQQNPSLLP
     ALLQQIGREN PQLLQQISQH QEHFIQMLNE PVQEAGGQGG GGGGGGGGGG GGGGIAEAGS
     GHMNYIQVTP QEKEAIERLK ALGFPEGLVI QAYFACEKNE NLAANFLLQQ NFDED
//
